Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06473610

Residual Embolism Evaluated With Single Photon Emission Computed Tomography

Residual Embolism Evaluated With Single Photon Emission Computed Tomography - The RESPECT Cohort

Status
Recruiting
Phase
Study type
Observational
Enrollment
358 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary vascular obstruction (RPVO) which can be assessed by pulmonary scintigraphy.

Detailed description

Planar ventilation/perfusion (V/Q) scintigraphy is the gold standard, but for several months, V/Q single photon emission computed tomography (SPECT) is recommended in the guidelines. The aim of this study is to evaluate the performances of various SPECT protocols to quantified RPVO and compared to planar scintigraphy to evaluate the RPVO.

Conditions

Timeline

Start date
2024-06-27
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2024-06-25
Last updated
2025-08-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06473610. Inclusion in this directory is not an endorsement.

Residual Embolism Evaluated With Single Photon Emission Computed Tomography (NCT06473610) · Clinical Trials Directory